Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

With Congress weighing insulin cost cap, Sanofi slashes price for uninsured in US
Fierce Pharma
Wed, 06/29/22 - 05:24 pm
Tags:
Sanofi, insulin, drug pricing, diabetes
Two for two: Sanofi snares twin European nods for enzyme replacement therapies
MedCity News
Tue, 06/28/22 - 05:42 pm
Tags:
Sanofi, Europe, Xenpozyme, Nexviazyme, enzyme replacement
Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
Motley Fool
Mon, 06/27/22 - 10:12 am
Tags:
Sanofi, Regeneron, FDA, Dupixent, eosinophilic esophagitis
Sanofi, GSK tout 72% Omicron efficacy in PhIII trial of next-gen, bivalent shot — with an eye to year-end rollout
Endpoints
Fri, 06/24/22 - 10:56 am
Tags:
Sanofi, GSK, COVID-19, COVID-19 variants, clinical trials, vaccines
CDC's ACIP recommends higher dose, Seqirus, Sanofi flu vaccines in adults 65 and older
Endpoints
Thu, 06/23/22 - 07:55 pm
Tags:
CDC, ACIP, vaccines, Seqirus, Sanofi, flu vaccines, Fluad, Fluzone, FluBlok
Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern
Yahoo/Benzinga
Mon, 06/13/22 - 10:32 am
Tags:
Sanofi, GSK, vaccines, COVID-19, COVID-19 variants, clinical trials
Sanofi union members set strike date in Korea as wage negotiations stall: report
Fierce Pharma
Sun, 06/12/22 - 08:20 pm
Tags:
Sanofi, South Korea, strike, unions
Following tie-up with Sanofi, transatlantic AI firm secures latest Big Pharma deal in nine-figure Bristol Myers pact
Endpoints
Wed, 06/8/22 - 11:07 pm
Tags:
Owkin, artificial intelligence, Sanofi, Bristol Myers Squibb
FDA approves Sanofi and Regeneron’s Dupixent for atopic dermatitis in young children
Pharmaceutical Business Review
Wed, 06/8/22 - 10:44 am
Tags:
Sanofi, Regeneron, FDA, pediatric, atopic dermatitis, Dupixent
Sanofi and Immunocore Pair High Potential Molecules for Metastatic Skin Cancers
BioSpace
Sun, 06/5/22 - 11:31 pm
Tags:
Immunocore, Sanofi, clinical trials, SAR444245, skin cancer
Regeneron purchases Sanofi’s stake in Libtayo collaboration
Biopharma Reporter
Thu, 06/2/22 - 10:27 am
Tags:
Regeneron, Sanofi, Libtayo
Sanofi: FDA Grants Efanesoctocog Alfa Breakthrough Therapy Designation For Hemophilia A
NASDAQ
Wed, 06/1/22 - 09:35 am
Tags:
Sanofi, FDA, breakthrough designation, hemophilia A, efanesoctocog alfa
FDA grants speedy review to Dupixent rare skin disease
Pharmaforum
Tue, 05/31/22 - 10:43 am
Tags:
Sanofi, Regeneron, Dupixent, prurigo nodularis, FDA
Sanofi's Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitis
Fierce Pharma
Sun, 05/22/22 - 09:15 pm
Tags:
Sanofi, Regeneron, Dupixent, FDA, eosinophilic esophagitis
Sanofi's $20B buyout of Genzyme pays off again with European OK for first Niemann-Pick drug
Endpoints
Fri, 05/20/22 - 10:30 am
Tags:
Sanofi, Genzyme, M&A, Europe, Niemann-Pick disease, Xenpozyme, olipudase alfa
French court rules against Sanofi in landmark Depakine case
Endpoints
Tue, 05/17/22 - 10:33 am
Tags:
legal, Sanofi, France, Depakine, epilepsy, birth defects, pregnancy
Big pharma’s biggest spenders revealed
EP Vantage
Tue, 05/17/22 - 10:29 am
Tags:
R&D, licensing, M&A, COVID-19, Big Pharma, Bristol Myers Squibb, JNJ, AbbVie, Sanofi, Merck, Novartis, Pfizer, AstraZeneca, Roche, GSK, Eli Lilly
Eli Lilly, Novo Nordisk and Sanofi face new lawsuit from Arkansas AG over insulin prices
Fierce Pharma
Thu, 05/12/22 - 10:54 pm
Tags:
Eli Lilly, Novo Nordisk, Sanofi, Arkansas, insulin, drug pricing, PBMs, diabetes
AZ, Sanofi build case for one-shot RSV antibody
Pharmaforum
Wed, 05/11/22 - 10:31 am
Tags:
AstraZeneca, Sanofi, RSV, nirsevimab
As Sanofi prunes pipeline, ex-Alexion crew at Rallybio picks up anemia drug
Endpoints
Tue, 05/10/22 - 10:56 am
Tags:
Sanofi, Rallybio, KY1066, RLYB331, Kymab, anemia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.